PAA

5.26%

18.0¢

PHARMAUST LIMITED

Market Cap $71.26M Add to my watchlist

Healthcare

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) is stepping up its trial activities in Australia’s nearest Asian neighbour, Indonesia. Recce’s flagship anti-infective, R327, can be applied as a gel – and this gel-based version of the drug has been of specific interest...

Latest Threads

Tag

Subject

PAA

Pharmaust to test MPL effectiveness on Alzheimer's and Parkinson's

15/05/24

4.8K

15/05/24

Last post pi065509

4.8K

PAA Biotech

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst

22 23 24

15/05/24

1.4K

345K

15/05/24

Last post FloatingCity

1.4K

345K

PAA

Ann: Investor update

14/05/24

5.5K

14/05/24

Last post JackBNimble

5.5K

PAA

Ann: Final Director's Interest Notice

14/05/24

329

14/05/24

Last post

ASX News

329

PAA

Ann: Board Changes

3 4 5

14/05/24

250

58K

14/05/24

Last post Buckland

250

58K

PAA

Corporate action

2 3 4

12/05/24

239

61K

12/05/24

Last post TheBrownHornet

239

61K

PAA

Ann: Initial Director's Interest Notice x 2

11/05/24

2.3K

11/05/24

Last post Buckland

2.3K

PAA

Ann: Trading Halt

10/05/24

23K

10/05/24

Last post Bunter62

23K

See All Discussions

Timeline

Final Director's Interest Notice
14 May 08:23	Share

Investor update
14 May 08:23	Share

Final Director's Interest Notice X 3
10 May 17:35	Share

Initial Director's Interest Notice x 2
10 May 17:19	Share

Cleansing Notice
09 May 09:25	Share

Application for quotation of securities - PAA
09 May 09:25	Share

Board Changes
09 May 09:25	Share

Trading Halt
07 May 09:42	Share

Appendix 4C & Quarterly Update
30 Apr 08:22	Share

Resignation of Dr Michael Thurn & appointment of John Clark
23 Apr 08:58	Share

Cleansing Notice
19 Apr 12:14	Share

Application for quotation of securities - PAA
19 Apr 12:13	Share

PharmAust makes Head of Manufacturing appointment
18 Apr 08:24	Share

Final Ethics Approval for Open-Label MND Extension Study
10 Apr 10:08	Share

Cleansing Notice
05 Apr 10:00	Share

Application for quotation of securities - PAA
05 Apr 09:59	Share

Media clarification
02 Apr 15:01	Share

Trading Halt
02 Apr 09:56	Share

Pause in Trading
02 Apr 09:53	Share

Cleansing Notice
27 Mar 17:02	Share

Application for quotation of securities - PAA
27 Mar 17:02	Share

PharmAust to present at NWR Virtual Healthcare Conference
19 Mar 09:36	Share

Singapore Healthcare Day Presentation
14 Mar 18:24	Share

Positive clinical data filed with FDA to support ODD request
14 Mar 09:13	Share

Cleansing Notice
07 Mar 08:17	Share

Application for quotation of securities - PAA
07 Mar 08:17	Share

Appendix 4D & Half-Year Report
29 Feb 16:04	Share

Cleansing Notice
28 Feb 20:15	Share

Application for quotation of securities - PAA
28 Feb 20:15	Share

Presentation - Phase 1 Top-Line Results
27 Feb 17:17	Share

View More

(20min delay)
Last 18.0¢		Change -0.010(5.26%)		Mkt cap ! $71.26M

Open	High	Low	Value	Volume
19.0¢	19.5¢	18.0¢	$184.0K	982.2K

Buyers (Bids)

No.	Vol.	Price($)
8	176820	18.0¢

Sellers (Offers)

Price($)	Vol.	No.
18.5¢	167405	5

View Market Depth

No.	Vol.	Price($)
8	176820	0.180
10	83215	0.175
12	377095	0.170
7	360499	0.165
6	134812	0.160

Price($)	Vol.	No.
0.185	167405	5
0.190	100000	1
0.195	189290	3
0.200	82000	4
0.205	72843	3

Last trade - 16.10pm 15/05/2024 (20 minute delay)


Last 18.0¢		Change -0.010 ( 5.26 %)
Open	High	Low	Volume
19.5¢	19.5¢	18.0¢	438529
Last updated 15.59pm 15/05/2024 ?

PAA (ASX) Chart

PHARMAUST LIMITED

Latest Threads

Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing

Timeline

Featured News

Latest Videos

PharmAust (ASX:PAA) reports ongoing positive outcomes for canine cancer treatment

07 Mar 2023 14:53 (AEDT)

PharmAust (ASX:PAA) to gain European patent for cancer-killing MPL combinations

28 Feb 2023 10:59 (AEDT)

PharmAust (ASX:PAA) doses first patient of MND trial's second cohort

20 Feb 2023 14:00 (AEDT)

Latest Articles

PharmAust CEO's sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.

PharmAust teams up with Berry Consultants for phase 2/3 MND study

PharmAust (ASX:PAA) is collaborating with renowned clinical study design expert, Berry Consultants, to design and analyse its planned phase 2/3 study for monepantel in patients with MND and ALS.

Pharmaust completes Phase One Monepantel study and files for Orphan Drug Designation

Pharmaust (ASX:PAA) has announced that all patients have completed its phase one MEND study using monepantel (MPL) to test its functions on Motor Neuron Disease (MND).

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News